Partners Value Investments L.P. Announces Q1 2024 Interim Results
TORONTO, May 17, 2024 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (the “Partnership”, TSX: PVF.UN TSX:PVF.PR.U) announced today its financial […]
Golconda Gold Ltd. Announces Commencement of Mining at Princeton Top
TORONTO, May 17, 2024 (GLOBE NEWSWIRE) — Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is […]
Partners Value Investments Inc. Announces Q1 2024 Interim Results
TORONTO, May 17, 2024 (GLOBE NEWSWIRE) — Partners Value Investments Inc. (the “Company”, TSX: PVF.WT, PVF.PR.V) announced today its financial […]
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
SOUTH SAN FRANCISCO, Calif., May 17, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) announced that the Company will host […]
GameStop Announces First Quarter Preliminary Results
GRAPEVINE, Texas, May 17, 2024 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced certain preliminary […]
JOYY to Announce First Quarter 2024 Financial Results on May 28, 2024
SINGAPORE, May 17, 2024 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: YY) (“JOYY” or the “Company”), a global technology company, today […]
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
Longer follow up and subset analyses from the pivotal FELIX Phase 2 data to be presented in oral presentations at […]
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences
TEL AVIV, Israel, May 17, 2024 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company […]
Village Farms International Applauds Historic Move Toward U.S. Marijuana Rescheduling
VANCOUVER, British Columbia and ORLANDO, Fla., May 17, 2024 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms”) (NASDAQ: VFF) […]
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that […]
